ProvenMed names Dr. Nadia Boutaoui to board of advisors

UAE—ProvenMed, a leading MedTech innovator based in the UAE, has appointed Dr. Nadia Boutaoui to its Board of Advisors, marking a significant step in the company’s mission to advance healthcare technology with dignity-centred solutions.

ProvenMed specializes in smart wearable devices and home-based urine analysis, aiming to improve continence care and empower patients with privacy and autonomy.

Dr. Boutaoui brings a wealth of expertise to ProvenMed, with a distinguished background in medical genetics, public health, and biotechnology.

Her extensive leadership experience spans clinical research and healthcare equity, where she has successfully translated cutting-edge scientific discoveries into scalable, patient-focused innovations.

Throughout her career, she has held influential advisory and executive roles, bridging the gap between breakthrough research and practical healthcare solutions.

Amine Staali, CEO of ProvenMed, expressed enthusiasm about Dr. Boutaoui’s addition to the board, emphasizing how her scientific knowledge and global outlook align perfectly with the company’s vision.

He highlighted that as ProvenMed accelerates the rollout of its flagship products—Livv® Smart Analysis Kit and the upcoming ActivGo® wearable device—her strategic guidance will be invaluable.

The Livv® kit enables intelligent urinalysis from the comfort of home, while ActivGo® offers a discreet solution for managing urinary incontinence, both designed to enhance user dignity and health management.

This appointment comes at a crucial moment for ProvenMed, as it prepares for the international launch of ActivGo® and continues to expand the reach of its Livv® platform across the Middle East and North Africa (MENA) region and beyond.

These innovations position ProvenMed as a leader in the growing field of intelligent home diagnostics and dignified healthcare solutions.

Dr. Boutaoui herself expressed pride in joining ProvenMed, noting that while innovation has the power to transform lives, its true impact is realized only when it reaches the market.

She praised ProvenMed for delivering practical, science-based, and user-centered products that are fast, focused, and private. She is committed to helping scale the company’s impact globally.

Dr. Nadia Boutaoui holds a Ph.D. in Genetics and an Executive MBA in Healthcare, with over 15 years of experience at the intersection of healthcare technology and innovation.

Her career includes leading NIH-funded research projects, mentoring healthcare startups, and founding NanoNares Inc., a life science company specializing in preclinical testing technologies.

Dr. Boutaoui is recognized for her expertise in AI-driven healthcare innovation and strategic growth, making her a valuable asset to ProvenMed’s advisory board.

ProvenMed’s mission is to empower individuals with autonomy and dignity through advanced medical technologies.

Its products, Livv® and ActivGo®, provide real-time health insights and discreet continence care solutions, addressing unmet needs in home diagnostics and chronic condition management.

With Dr. Boutaoui’s appointment, ProvenMed is well-positioned to accelerate its growth and deliver impactful health solutions worldwide.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.